VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 35 filers reported holding VINCERX PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $388,850 | -22.3% | 385,000 | 0.0% | 0.04% | -4.3% |
| Q2 2023 | $500,500 | +25.0% | 385,000 | 0.0% | 0.05% | -37.3% |
| Q1 2023 | $400,400 | +2.0% | 385,000 | 0.0% | 0.08% | -3.8% |
| Q4 2022 | $392,700 | -26.0% | 385,000 | 0.0% | 0.08% | +14.7% |
| Q3 2022 | $531,000 | +4.5% | 385,000 | 0.0% | 0.07% | -20.9% |
| Q2 2022 | $508,000 | -67.0% | 385,000 | 0.0% | 0.09% | -46.6% |
| Q1 2022 | $1,540,000 | -60.7% | 385,000 | 0.0% | 0.16% | -64.3% |
| Q4 2021 | $3,923,000 | -20.4% | 385,000 | +26.3% | 0.45% | -24.8% |
| Q3 2021 | $4,930,000 | +86.6% | 304,896 | +49.9% | 0.60% | +96.1% |
| Q2 2021 | $2,642,000 | – | 203,418 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,618,199 | $31,231,000 | 10.26% |
| Affinity Asset Advisors, LLC | 543,010 | $10,480,000 | 3.56% |
| ACUTA CAPITAL PARTNERS, LLC | 394,000 | $7,604,000 | 2.74% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $9,650,000 | 2.72% |
| Logos Global Management LP | 480,000 | $9,264,000 | 0.90% |
| Sio Capital Management, LLC | 105,000 | $2,027,000 | 0.41% |
| SABBY MANAGEMENT, LLC | 82,948 | $1,601,000 | 0.31% |
| Monashee Investment Management LLC | 99,999 | $1,930,000 | 0.30% |
| Ikarian Capital, LLC | 438,684 | $8,467,000 | 0.28% |
| RTW INVESTMENTS, LP | 500,000 | $9,650,000 | 0.15% |